FDA Proposes Revisions to Rules on the Protection of Human Subjects and Cooperative Research
28 September 2022 by CITI Program

The U.S. Food and Drug Administration (FDA) proposed two new rules that would update regulations 21 CFR 50 (Protection of Human Subjects) and 21 CFR…

Join the Clubhouse: Human Research Protection
15 November 2022 by CITI Program

Overview Have you heard about the Human Research Protection (HRP) club that is growing on the Clubhouse social audio app? If you’re curious, you can…

CITI Program’s November 2022 Media Playlist – Part 2
11 November 2022 by CITI Program

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…

On Campus Podcast – Title IX: Women in Athletics
11 November 2022 by CITI Program

Season 1 – Episode 25 – Title IX: Women in Athletics The Education Amendments of 1972 banned sex discrimination in federally funded educational programs and…

Updated Guidelines for Reporting Incidents to OHRP
10 November 2022 by CITI Program

The HHS Office for Human Research Protections (OHRP) issued an updated guidance, titled Reporting Incidents to OHRP (2022) to replace 2011’s Guidance on Reporting Incidents to…

What CITI Program is Reading – November 8th, 2022
8 November 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

On Campus Podcast – Universal Design: Campus Infrastructure
1 November 2022 by CITI Program

Season 1 – Episode 24 – Universal Design: Campus Infrastructure Universal design for learning is a framework which is often applied in educational settings to…

What CITI Program is Reading – November 1st, 2022
31 October 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

Proposed FDA Updates for the Breakthrough Devices Program Guidance
1 November 2022 by CITI Program

The U.S. Food and Drug Administration (FDA) issued a draft guidance, titled Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and…

CITI Program’s November 2022 Media Playlist – Part 1
31 October 2022 by CITI Program

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…

Best Practices for Clinical Site Selection
28 October 2022 by CITI Program

Overview Clinical trials are expensive and labor-intensive. Failures within the clinical trial process result in a huge loss of valuable resources and time. [1] These…

On Campus Podcast – Open Access: Federal Rule Change
26 October 2022 by CITI Program

Season 1 – Episode 23: Open Access: Federal Rule Change As open access continues to become more prominent in the field of academic publishing, it…